Lifechart, a health-tech startup focused on gut wellness, has raised $360,000 in an extended seed round for its premium gut health brand Guttify, led by Prajay Advisors, the family office of the founders of Unichem Labs, Dr. Prakash Mody and Jayendra Shah.
The funds raised will be used to expand diagnostic R&D, grow distribution, and scale both Guttify and Lifechart’s product portfolio.
This $360K raise follows a $500K seed round in October 2024, bringing Lifechart’s total funding to over $1 million in record time.
Founded in 2022 by Mukul Shah and Mansi Sharma, Guttify focuses on diagnosis-first gut wellness solutions tailored for India’s urban and semi-urban populations. The brand offers do-it-yourself at-home gut health test kits and clinically validated regimens that integrate modern medical research with Ayurvedic principles.
Guttify combines clinically validated products, instant DIY diagnostic kits, and personalized Ayurveda-based regimens.
Guttify’s first offering, a DIY saliva-based pH test kit to detect acidity, is already available on the official website of Guttify, with more kits priced as low as INR 99 set to launch in the coming months.
With Guttify, Lifechart is positioning itself as a category creator, aiming to bring precision diagnostics and targeted gut wellness to India’s urban masses—starting with Tier 1 and Tier 2 cities.
Mukul Shah, Founder & CEO of Lifechart, said, “We are solving gut health at its root through affordable at-home testing and personalized care. Guttify is not just a product brand, it’s a wellness ecosystem built on diagnosis-first science.”
Prakash Mody and Jayendra Shah said, “We see Guttify filling a glaring gap in India’s gut health space—diagnosis. We’re excited to support Mukul again in his mission to build the Indian version of Viome, tailored for Bharat’s needs. His execution ability, proven with Yolo Bus, gives us strong confidence in Guttify’s future.”
